Danazol in the treatment of benign breast disease
Other
OA: closed
CC0
⤵ 8 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper investigated the efficacy of danazol in treating benign breast disease.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
Cited by (8)
- Ultrastructural features of danazol-induced cholestasis: a case study 1996
- Postmenopausal endometrial hyperplasia: role of danazol therapy 1994
- Treatment of recurrent cyclical mastodynia in patients with fibrocystic breast disease. A double-blind placebo-controlled study--the Hjørring project 1984
- Danazol treatment of severely symptomatic fibrocystic breast disease and long-term follow-up--the Hjørring project 1984
- Progestin-like effects of danazol on rabbit uterus 1983
- Successful treatment of D-penicillamine-induced breast gigantism with danazol 1981
- Successful treatment of D-penicillamine-induced breast gigantism with danazol 1981
- Danazol for benign breast disease 1980
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-10-08T22:00:16.042305+00:00
License: CC0
· commercial use OK